Clinical Research

The Foundation invests in clinical research which ensures that St. Anthony’s Hospital remains at the forefront of the most advanced clinical practices and technologies.

In 2026, the Foundation received a grant, available for funding, that supports stroke research.

Stroke-associated pneumonia affects up to 25–30% of acute stroke patients and significantly increases hospitalization, costs, and mortality. This two-site prospective study will assess whether blood biomarkers can predict pneumonia risk and correlate with stroke severity and recovery. This project supports St. Anthony’s Hospital’s pursuit of DNV Comprehensive Stroke Center status.

In 2025, the Foundation funded another study called Cystatin C AKI. Serum Cystatin C is hypothesized to improve the early detection of contrast-induced acute kidney injury with pre-existing chronic kidney disease.

If you are interested in funding clinical research such as the studies above, contact Amy Leuschke, Director of Development, at 727-825-1109 or Amy.Leuschke@baycare.org or contact Kathy Parker, Executive Director, at 727-820-7318 or Kathy.Parker1@baycare.org.